Bioclinica Acquires Synowledge

NEWTOWN, Pa. - September 21, 2015 – BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that it has acquired Synowledge to expand its offering into the growing drug safety and regulatory business process outsourcing market. Headquartered in Miami, Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies with recording, analyzing and reporting adverse drug events. "This acquisition extends BioClinica's solutions into an important new area for our customers," said BioClinica President and Chief Executive Officer John Hubbard. "Synowledge is a highly regarded provider t